Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2

Elide Mantuano, Silvia Romano, Liana Veneziano, Cinzia Gellera, Barbara Castellotti, Sara Caimi, Daniela Testa, Margherita Estienne, Giovanna Zorzi, Marianna Bugiani, Yusuf A. Rajabally, Maria J Garcìa Barcina, Serena Servidei, Aurora Panico, Marina Frontali, Caterina Mariotti

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Episodic ataxia type 2 is a rare autosomal dominant disease characterized by recurrent attacks of vertigo and cerebellar ataxia. The disease was caused by mutations in the CACNA1A gene, on chromosome 19p. We perform a mutational screening in a group of 43 unrelated patients. Forty-two patients presented episodes of disequilibrium and ataxia, and one child was studied because of the occurrence of episodic torticollis. The genetic analysis showed 15 mutated patients (35%). In 13 cases we found novel CACNA1A gene mutations, including missense, protein truncating, and aberrant splicing mutations. Two truncating mutations lead to the uppermost premature stop so far reported, challenging recent hypotheses on dominant negative effect. In patients without CACNA1A mutations, molecular testing for CACNB4 gene mutations excluded this genetic subtype. Clinical features of mutated subjects mostly confirmed previous sign and symptoms associated with EA2, including paroxysmal torticollis and mental retardation. CACNA1A mutated patients have an earlier age at onset, interictal nystagmus, and abnormalities of ocular movements. A review of all CACNA1A mutations so far reported showed that they are mainly located downstream exon 18. Our data substantially increase the number of the described CACNA1A mutations, and propose clinical and molecular criteria for a more focused genetic screening.

Original languageEnglish
Pages (from-to)30-36
Number of pages7
JournalJournal of the Neurological Sciences
Volume291
Issue number1-2
DOIs
Publication statusPublished - Apr 15 2010

Fingerprint

Mutation
Genes
Torticollis
Cerebellar Ataxia
Vertigo
Genetic Testing
Missense Mutation
Ataxia
Eye Movements
Type 2 Episodic Ataxia
Age of Onset
Intellectual Disability
Signs and Symptoms
Exons
Chromosomes
Proteins

Keywords

  • Acetazolamide
  • CACNA1A
  • Calcium channel
  • EA2
  • Episodic ataxia
  • Paroxysmal torticollis

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2. / Mantuano, Elide; Romano, Silvia; Veneziano, Liana; Gellera, Cinzia; Castellotti, Barbara; Caimi, Sara; Testa, Daniela; Estienne, Margherita; Zorzi, Giovanna; Bugiani, Marianna; Rajabally, Yusuf A.; Barcina, Maria J Garcìa; Servidei, Serena; Panico, Aurora; Frontali, Marina; Mariotti, Caterina.

In: Journal of the Neurological Sciences, Vol. 291, No. 1-2, 15.04.2010, p. 30-36.

Research output: Contribution to journalArticle

Mantuano, E, Romano, S, Veneziano, L, Gellera, C, Castellotti, B, Caimi, S, Testa, D, Estienne, M, Zorzi, G, Bugiani, M, Rajabally, YA, Barcina, MJG, Servidei, S, Panico, A, Frontali, M & Mariotti, C 2010, 'Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2', Journal of the Neurological Sciences, vol. 291, no. 1-2, pp. 30-36. https://doi.org/10.1016/j.jns.2010.01.010
Mantuano, Elide ; Romano, Silvia ; Veneziano, Liana ; Gellera, Cinzia ; Castellotti, Barbara ; Caimi, Sara ; Testa, Daniela ; Estienne, Margherita ; Zorzi, Giovanna ; Bugiani, Marianna ; Rajabally, Yusuf A. ; Barcina, Maria J Garcìa ; Servidei, Serena ; Panico, Aurora ; Frontali, Marina ; Mariotti, Caterina. / Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2. In: Journal of the Neurological Sciences. 2010 ; Vol. 291, No. 1-2. pp. 30-36.
@article{798b9c186b3546248f7df8617f06b88f,
title = "Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2",
abstract = "Episodic ataxia type 2 is a rare autosomal dominant disease characterized by recurrent attacks of vertigo and cerebellar ataxia. The disease was caused by mutations in the CACNA1A gene, on chromosome 19p. We perform a mutational screening in a group of 43 unrelated patients. Forty-two patients presented episodes of disequilibrium and ataxia, and one child was studied because of the occurrence of episodic torticollis. The genetic analysis showed 15 mutated patients (35{\%}). In 13 cases we found novel CACNA1A gene mutations, including missense, protein truncating, and aberrant splicing mutations. Two truncating mutations lead to the uppermost premature stop so far reported, challenging recent hypotheses on dominant negative effect. In patients without CACNA1A mutations, molecular testing for CACNB4 gene mutations excluded this genetic subtype. Clinical features of mutated subjects mostly confirmed previous sign and symptoms associated with EA2, including paroxysmal torticollis and mental retardation. CACNA1A mutated patients have an earlier age at onset, interictal nystagmus, and abnormalities of ocular movements. A review of all CACNA1A mutations so far reported showed that they are mainly located downstream exon 18. Our data substantially increase the number of the described CACNA1A mutations, and propose clinical and molecular criteria for a more focused genetic screening.",
keywords = "Acetazolamide, CACNA1A, Calcium channel, EA2, Episodic ataxia, Paroxysmal torticollis",
author = "Elide Mantuano and Silvia Romano and Liana Veneziano and Cinzia Gellera and Barbara Castellotti and Sara Caimi and Daniela Testa and Margherita Estienne and Giovanna Zorzi and Marianna Bugiani and Rajabally, {Yusuf A.} and Barcina, {Maria J Garc{\`i}a} and Serena Servidei and Aurora Panico and Marina Frontali and Caterina Mariotti",
year = "2010",
month = "4",
day = "15",
doi = "10.1016/j.jns.2010.01.010",
language = "English",
volume = "291",
pages = "30--36",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2

AU - Mantuano, Elide

AU - Romano, Silvia

AU - Veneziano, Liana

AU - Gellera, Cinzia

AU - Castellotti, Barbara

AU - Caimi, Sara

AU - Testa, Daniela

AU - Estienne, Margherita

AU - Zorzi, Giovanna

AU - Bugiani, Marianna

AU - Rajabally, Yusuf A.

AU - Barcina, Maria J Garcìa

AU - Servidei, Serena

AU - Panico, Aurora

AU - Frontali, Marina

AU - Mariotti, Caterina

PY - 2010/4/15

Y1 - 2010/4/15

N2 - Episodic ataxia type 2 is a rare autosomal dominant disease characterized by recurrent attacks of vertigo and cerebellar ataxia. The disease was caused by mutations in the CACNA1A gene, on chromosome 19p. We perform a mutational screening in a group of 43 unrelated patients. Forty-two patients presented episodes of disequilibrium and ataxia, and one child was studied because of the occurrence of episodic torticollis. The genetic analysis showed 15 mutated patients (35%). In 13 cases we found novel CACNA1A gene mutations, including missense, protein truncating, and aberrant splicing mutations. Two truncating mutations lead to the uppermost premature stop so far reported, challenging recent hypotheses on dominant negative effect. In patients without CACNA1A mutations, molecular testing for CACNB4 gene mutations excluded this genetic subtype. Clinical features of mutated subjects mostly confirmed previous sign and symptoms associated with EA2, including paroxysmal torticollis and mental retardation. CACNA1A mutated patients have an earlier age at onset, interictal nystagmus, and abnormalities of ocular movements. A review of all CACNA1A mutations so far reported showed that they are mainly located downstream exon 18. Our data substantially increase the number of the described CACNA1A mutations, and propose clinical and molecular criteria for a more focused genetic screening.

AB - Episodic ataxia type 2 is a rare autosomal dominant disease characterized by recurrent attacks of vertigo and cerebellar ataxia. The disease was caused by mutations in the CACNA1A gene, on chromosome 19p. We perform a mutational screening in a group of 43 unrelated patients. Forty-two patients presented episodes of disequilibrium and ataxia, and one child was studied because of the occurrence of episodic torticollis. The genetic analysis showed 15 mutated patients (35%). In 13 cases we found novel CACNA1A gene mutations, including missense, protein truncating, and aberrant splicing mutations. Two truncating mutations lead to the uppermost premature stop so far reported, challenging recent hypotheses on dominant negative effect. In patients without CACNA1A mutations, molecular testing for CACNB4 gene mutations excluded this genetic subtype. Clinical features of mutated subjects mostly confirmed previous sign and symptoms associated with EA2, including paroxysmal torticollis and mental retardation. CACNA1A mutated patients have an earlier age at onset, interictal nystagmus, and abnormalities of ocular movements. A review of all CACNA1A mutations so far reported showed that they are mainly located downstream exon 18. Our data substantially increase the number of the described CACNA1A mutations, and propose clinical and molecular criteria for a more focused genetic screening.

KW - Acetazolamide

KW - CACNA1A

KW - Calcium channel

KW - EA2

KW - Episodic ataxia

KW - Paroxysmal torticollis

UR - http://www.scopus.com/inward/record.url?scp=77349118451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77349118451&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2010.01.010

DO - 10.1016/j.jns.2010.01.010

M3 - Article

VL - 291

SP - 30

EP - 36

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -